Case number 2020-1673
Mylan Pharmaceuticals Inc. v. Biogen MA Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 30, 2022 | 0 | MYLAN PHARMACEUTICALS INC. v. BIOGEN MA INC. [ORDER] [nonprecedential] (0) |
| Apr 8, 2022 | 70 | ORDER filed granting-in-part petition for panel rehearing [64] filed by Appellant Mylan Pharmaceuticals Inc.; vacating Nonprecedential Opinion [60], judgment [61]; staying appeal. Please see order for full details. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [841972] [MVH] [Entered: 04/08/2022 12:19 PM] (2) |
| Apr 6, 2022 | 69 | 3 paper copies of Doc. No. [68] received from Appellee Biogen MA, Inc.. [841794] [VDW] [Entered: 04/07/2022 04:13 PM] (0) |
| Apr 4, 2022 | 68 | RESPONSE of Appellee Biogen MA, Inc. to Doc No. [64]. Service: 04/04/2022 by email. [840734] [20-1673] [William Lee] [Entered: 04/04/2022 02:15 PM] (17) |
| Apr 4, 2022 | 67 | Amended Certificate of Interest for Appellee Biogen MA, Inc.. Service: 04/04/2022 by email. [840732] [20-1673] [William Lee] [Entered: 04/04/2022 02:13 PM] (3) |
| Mar 21, 2022 | 66 | The court invites a response from Biogen MA, Inc. to the petition [64]. Response due 04/04/2022. Service as of this date by the Clerk of Court. [837984] [MJL] [Entered: 03/21/2022 03:07 PM] (1) |
| Jan 31, 2022 | 65 | 3 paper copies of Doc. No. [64] received from Appellant Mylan Pharmaceuticals Inc.. [828303] [VDW] [Entered: 02/01/2022 11:44 AM] (0) |
| Jan 28, 2022 | 64 | Petition for panel rehearing filed by Appellant Mylan Pharmaceuticals Inc.. Service: 01/28/2022 by email. [827703] [20-1673] [Nathan Kelley] [Entered: 01/28/2022 01:45 PM] (53) |
| Dec 28, 2021 | 63 | ORDER filed granting motion to extend time to file petition for rehearing/en banc [62] filed by Appellant Mylan Pharmaceuticals Inc.. Petition for Rehearing due on or before 01/28/2022. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [821536] [MVH] [Entered: 12/28/2021 12:40 PM] (2) |
| Dec 23, 2021 | 0 | MYLAN PHARMACEUTICALS INC. v. BIOGEN MA INC. [OPINION] [nonprecedential] (0) |
| Dec 23, 2021 | 62 | MOTION of Appellant Mylan Pharmaceuticals Inc. to extend the time to file a Petiton for Panel Rehearing until 01/28/2022. Service: 12/23/2021 by email. [821063] [20-1673] [Nathan Kelley] [Entered: 12/23/2021 03:05 PM] (8) |
| Nov 30, 2021 | 61 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [815287]. Vacated pursuant to the court's order. See Doc. No. [70] [MJL] [Entered: 11/30/2021 10:50 AM] (1) |
| Nov 30, 2021 | 60 | OPINION filed for the court by O'Malley, Circuit Judge; Reyna, Circuit Judge and Hughes, Circuit Judge. Nonprecedential Opinion. Service as of this date by the Clerk of Court. [815286]. Vacated pursuant to the court's order. See Doc. No. [70] [MJL] [Entered: 11/30/2021 10:49 AM] (3) |
| Jan 5, 2021 | 59 | Amended Certificate of Interest for Appellee Biogen MA Inc.. Service: 01/05/2021 by email. [747071] [20-1673] [William Lee] [Entered: 01/05/2021 04:39 PM] (0) |
| Dec 31, 2020 | 58 | **TEXT ONLY** ORDER granting motion to withdraw William G. McElwain [57] as counsel for Biogen MA Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [746179] [MJL] [Entered: 12/31/2020 10:12 AM] (0) |
| Dec 30, 2020 | 57 | MOTION of Appellee Biogen MA Inc. to withdraw counsel William G. McElwain. Service: 12/30/2020 by email. [746096] [20-1673] [William McElwain] [Entered: 12/30/2020 04:41 PM] (0) |
| Dec 8, 2020 | 56 | Submitted after ORAL ARGUMENT to Panel: O'Malley, Circuit Judge; Reyna, Circuit Judge and Hughes, Circuit Judge.Arguing counsel: Nathan K. Kelley for Mylan Pharmaceuticals Inc. and William F. Lee for Biogen MA Inc.Oral Argument Audio available here. [741081] [JAB] [Entered: 12/08/2020 12:14 PM] (0) |
| Dec 2, 2020 | 55 | Amended Certificate of Interest for Appellant Mylan Pharmaceuticals Inc.. Service: 12/02/2020 by clerk. [739790] [20-1673] [Andrew Dufresne] [Entered: 12/02/2020 05:57 PM] (0) |
| Nov 20, 2020 | 54 | RESPONSE of Appellant Mylan Pharmaceuticals Inc. to the supplemental authority [52]. Service: 11/20/2020 by email. [737293] [20-1673] [Nathan Kelley] [Entered: 11/20/2020 12:15 PM] (0) |
| Nov 19, 2020 | 53 | Clerk's letter to Appellant Mylan Pharmaceuticals Inc. and Appellee Biogen MA Inc. in 20-1673, Appellants Biogen International GmbH, Biogen MA, Inc. and Appellee Mylan Pharmaceuticals Inc. in 20-1933 regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [736892] [20-1673, 20-1933] [JAB] [Entered: 11/19/2020 11:14 AM] (0) |
| Nov 18, 2020 | 52 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellee Biogen MA Inc.. Service: 11/18/2020 by email. [736754] [20-1673] [William Lee] [Entered: 11/18/2020 04:43 PM] (0) |
| Nov 16, 2020 | 50 | Response to notice of oral argument from Appellee Biogen MA Inc.. Service: 11/16/2020 by email. [735633] [20-1673] [William Lee] [Entered: 11/16/2020 09:19 AM] (0) |
| Nov 16, 2020 | 51 | Response to notice of oral argument from Appellant Mylan Pharmaceuticals Inc.. Service: 11/16/2020 by email. [736012] [20-1673] [Nathan Kelley] [Entered: 11/16/2020 04:39 PM] (0) |
| Oct 21, 2020 | 49 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2012E. Case scheduled December 8, 2020. Response to Notice of Oral Argument due: 11/16/2020. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [730571] [JAB] [Entered: 10/21/2020 02:06 PM] (1) |
| Oct 16, 2020 | 48 | 6 paper copies of Doc. Nos. [28], [37], [41] received from Mylan Pharmaceuticals Inc. [730326] [MJL] [Entered: 10/20/2020 04:12 PM] (0) |
| Oct 15, 2020 | 46 | The following conflict dates submitted by William F. Lee for Biogen MA Inc. have been accepted by the court: 12/07/2020, 02/01/2021, 03/01/2021, 03/02/2021, 05/03/2021, 05/04/2021, 05/05/2021, 05/06/2021, 05/07/2021. [728835] [JAB] [Entered: 10/15/2020 09:20 AM] (0) |
| Oct 14, 2020 | 45 | Notice from Appellant Mylan Pharmaceuticals Inc. regarding conflicts with oral argument. None. Service: 10/14/2020 by email. [728717] [20-1673] [Nathan Kelley] [Entered: 10/14/2020 05:01 PM] (0) |
| Oct 14, 2020 | 44 | Notice from Appellee Biogen MA Inc. regarding conflicts with oral argument. Service: 10/14/2020 by email. [728605] [20-1673] [William Lee] [Entered: 10/14/2020 01:20 PM] (3) |
| Oct 9, 2020 | 47 | Two sets of 6 paper copies of Doc. No. [35] received from Biogen MA Inc (one blue, one red). [730319] [MJL] [Entered: 10/20/2020 04:02 PM] (0) |
| Oct 7, 2020 | 43 | Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before October 21, 2020. See Administrative Order No. 20-01 (Mar. 20, 2020). [727434] [LMN] [Entered: 10/07/2020 02:59 PM] (0) |
| Oct 7, 2020 | 42 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [727431] [LMN] [Entered: 10/07/2020 02:56 PM] (1) |
| Oct 7, 2020 | 41 | MODIFIED ENTRY: CORRECTED APPENDIX FILED by Appellant Mylan Pharmaceuticals Inc. Service: 10/07/2020 by email. [727386] --[Edited 10/07/2020 by LMN - compliance review complete] [Nathan Kelley] [Entered: 10/07/2020 01:56 PM] (1285) |
| Oct 5, 2020 | 38 | APPENDIX FILED by Appellant Mylan Pharmaceuticals Inc.. Service: 10/05/2020 by email. This document has been corrected. See doc. [41] [726678] [20-1673]--[Edited 10/07/2020 by LMN] [Nathan Kelley] [Entered: 10/05/2020 04:20 PM] (1283) |
| Oct 5, 2020 | 40 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellee Biogen MA Inc. and Appellant Mylan Pharmaceuticals Inc.. Service: 10/05/2020 by email. [726682] [20-1673] [Nathan Kelley] [Entered: 10/05/2020 04:23 PM] (2) |
| Oct 5, 2020 | 39 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant Mylan Pharmaceuticals Inc.. Service: 10/05/2020 by email. [726679] [20-1673] [Nathan Kelley] [Entered: 10/05/2020 04:21 PM] (2) |
| Sep 30, 2020 | 37 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Mylan Pharmaceuticals Inc. Service: 09/30/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [725671] --[Edited 10/02/2020 by LMN - compliance review complete] [Nathan Kelley] [Entered: 09/30/2020 08:51 PM] (36) |
| Sep 28, 2020 | 36 | Entry of appearance for Andrew T. Dufresne as counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 09/28/2020 by clerk. [724920] [20-1673] [Andrew Dufresne] [Entered: 09/28/2020 03:40 PM] (1) |
| Sep 17, 2020 | 33 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Biogen MA Inc., Response Brief [31], [32], is not in compliance with the rules of this court (see attached). Compliant document is due on 09/24/2020. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [722336] [LMN] [Entered: 09/17/2020 08:15 AM] (1) |
| Sep 17, 2020 | 34 | Notice of Correction to Doc No. [31] for Appellee Biogen MA Inc.. Service: 09/17/2020 by email. [722398] [20-1673] [William Lee] [Entered: 09/17/2020 10:19 AM] (5) |
| Sep 17, 2020 | 35 | MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED by Appellee Biogen MA Inc.. Service: 09/17/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of original submission. See Fed. Cir. R. 31. [722401] --[Edited 09/23/2020 by LMN - compliance review complete] [William Lee] [Entered: 09/17/2020 10:22 AM] (69) |
| Sep 11, 2020 | 30 | Amended Certificate of Interest for Appellee Biogen MA Inc.. Service: 09/11/2020 by email. [721043] [20-1673] [William Lee] [Entered: 09/11/2020 02:35 PM] (3) |
| Sep 11, 2020 | 31 | FILED from Appellee Biogen MA Inc.. Title: RESPONSE BRIEF. Service: 09/11/2020 by email. This document has been corrected. See doc. [35] [721121] [20-1673] This document is non-compliant. See Doc No. [33]--[Edited 09/23/2020 by LMN] [Yvonne Lee] [Entered: 09/11/2020 07:32 PM] (69) |
| Sep 11, 2020 | 32 | FILED from Appellee Biogen MA Inc.. Title: RESPONSE BRIEF. Service: 09/11/2020 by email. This document has been corrected. See doc. [35] [721122] [20-1673] This document is non-compliant. See Doc No. [33]--[Edited 09/23/2020 by LMN] [William Lee] [Entered: 09/11/2020 07:39 PM] (69) |
| Sep 10, 2020 | 29 | Entry of appearance for James B. Monroe; Paul W. Browning as counsel for Appellee Biogen MA Inc.. Service: 09/10/2020 by email. [720699] [20-1673] [James Monroe] [Entered: 09/10/2020 12:21 PM] (2) |
| Aug 10, 2020 | 28 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED for Appellant Mylan Pharmaceuticals Inc. Number of Pages: 33. Service: 08/10/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [713892] --[Edited 08/13/2020 by LMN - compliance review complete] [Nathan Kelley] [Entered: 08/10/2020 05:23 PM] (132) |
| Aug 7, 2020 | 27 | FILED from Appellant Mylan Pharmaceuticals Inc. Title: OPENING BRIEF. Service: 08/07/2020 by email. This document has been corrected. See doc. [28] [713514] [20-1673]--[Edited 08/13/2020 by LMN] [Nathan Kelley] [Entered: 08/07/2020 07:31 PM] (130) |
| Aug 7, 2020 | 26 | FILED from Appellant Mylan Pharmaceuticals Inc. Title: OPENING BRIEF. Service: 08/07/2020 by email. This document has been corrected. See doc. [28] [713503] [20-1673] --[Edited 08/13/2020 by LMN]--[Edited 08/13/2020 by LMN] [Nathan Kelley] [Entered: 08/07/2020 06:31 PM] (44) |
| Aug 7, 2020 | 25 | Entry of appearance for Dan L. Bagatell; Courtney M. Prochnow as counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 08/07/2020 by email. [713310] [20-1673] [Dan Bagatell] [Entered: 08/07/2020 11:22 AM] (2) |
| Jul 28, 2020 | 24 | ORDER filed granting the motions [23] [707515-2] to the following extent: (1) the above-captioned appeals shall be considered companion cases and assigned to the same merits panel; and (2) in each of the above-captioned appeals, the opening brief is due no later than August 7, 2020; the response brief is due no later than September 11, 2020; the reply brief is due no later than September 30, 2020; the joint appendix is due no later than October 5, 2020; and the cases will be placed on the next available oral argument calendar after briefing is complete in both of the appeals. Service as of this date by the Clerk of Court. [710733] [20-1673, 20-1933] [LMS] [Entered: 07/28/2020 04:25 PM] (2) |
| Jul 14, 2020 | 23 | MOTION of Appellee Biogen MA Inc. to expedite briefing schedule [Consent: unopposed]. Service: 07/14/2020 by email. [707514] [20-1673] [William Lee] [Entered: 07/14/2020 04:48 PM] (8) |
| Jul 14, 2020 | 22 | Entry of appearance for Lisa J. Pirozzolo; Annaleigh E. Curtis; Madeleine C. Laupheimer; Scott G. Greene; William G. McElwain as counsel for Appellee Biogen MA Inc.. Service: 07/14/2020 by email. [707472] [20-1673] [Lisa Pirozzolo] [Entered: 07/14/2020 03:38 PM] (2) |
| Jul 14, 2020 | 21 | **TEXT ONLY** ORDER granting motion to extend time to file brief [20] filed by Appellant Mylan Pharmaceuticals Inc. The opening brief is due 08/07/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [707285] [LMN] [Entered: 07/14/2020 09:41 AM] (0) |
| Jul 13, 2020 | 20 | MOTION of Appellant Mylan Pharmaceuticals Inc. to extend the time to 08/07/2020 to file the opening brief. [Consent: unopposed]. Service: 07/13/2020 by email. [707162] [20-1673] [Nathan Kelley] [Entered: 07/13/2020 05:16 PM] (5) |
| Jul 10, 2020 | 19 | Entry of appearance for William F. Lee; Thomas G. Saunders as counsel for Appellee Biogen MA Inc.. Service: 07/10/2020 by email. [706834] [20-1673] [William Lee] [Entered: 07/10/2020 05:14 PM] (2) |
| Jun 4, 2020 | 18 | Entry of appearance for Matthew F. Greinert as of counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 06/04/2020 by email. [699282] [20-1673] [Matthew Greinert] [Entered: 06/04/2020 02:58 PM] (1) |
| May 20, 2020 | 17 | REMINDER: Attorney Greb is reminded that the information on the Entry of Appearance (EOA) and the information in the user account must match. Please promptly update the EOA or the account information on www.pacer.gov.[695866] [LMN] [Entered: 05/20/2020 10:42 AM] (0) |
| May 20, 2020 | 16 | Certified list received. Service: 05/19/2020 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [695819] [LMN] [Entered: 05/20/2020 09:04 AM] (63) |
| May 19, 2020 | 15 | Entry of appearance for Emily J. Greb as of counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 05/19/2020 by email. [695648] [20-1673] [Nathan Kelley] [Entered: 05/19/2020 12:40 PM] (2) |
| Apr 23, 2020 | 12 | Entry of appearance for Nathan K. Kelley as of counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 04/23/2020 by email. [689553] [20-1673] [Nathan Kelley] [Entered: 04/23/2020 03:31 PM] (1) |
| Apr 23, 2020 | 11 | Entry of appearance for David L. Anstaett as of counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 04/23/2020 by email. [689551] [20-1673] [Nathan Kelley] [Entered: 04/23/2020 03:26 PM] (2) |
| Apr 23, 2020 | 10 | Entry of appearance for Brandon M. White as of counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 04/23/2020 by email. [689550] [20-1673] [Nathan Kelley] [Entered: 04/23/2020 03:25 PM] (2) |
| Apr 23, 2020 | 9 | Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 04/23/2020 by email. [689549] [20-1673] [Nathan Kelley] [Entered: 04/23/2020 03:23 PM] (2) |
| Apr 23, 2020 | 14 | Docketing Statement for the Appellant Mylan Pharmaceuticals Inc.. Service: 04/23/2020 by email. [689556] [20-1673] [Nathan Kelley] [Entered: 04/23/2020 03:35 PM] (2) |
| Apr 23, 2020 | 13 | Certificate of Interest for Appellant Mylan Pharmaceuticals Inc.. Service: 04/23/2020 by email. [689555] [20-1673] [Nathan Kelley] [Entered: 04/23/2020 03:33 PM] (1) |
| Apr 22, 2020 | 8 | Docketing Statement for the Appellee Biogen MA Inc.. Service: 04/22/2020 by email. [689292] [20-1673] [Barbara McCurdy] [Entered: 04/22/2020 04:49 PM] (3) |
| Apr 22, 2020 | 7 | Certificate of Interest for Appellee Biogen MA Inc.. Service: 04/22/2020 by email. [689290] [20-1673] [Barbara McCurdy] [Entered: 04/22/2020 04:45 PM] (2) |
| Apr 22, 2020 | 6 | Entry of appearance for Cora R. Holt as of counsel for Appellee Biogen MA Inc.. Service: 04/22/2020 by email. [689287] [20-1673] [Cora Holt] [Entered: 04/22/2020 04:38 PM] (1) |
| Apr 22, 2020 | 5 | Entry of appearance for Pier D. DeRoo as of counsel for Appellee Biogen MA Inc.. Service: 04/22/2020 by email. [689283] [20-1673] [Pier DeRoo] [Entered: 04/22/2020 04:34 PM] (1) |
| Apr 22, 2020 | 4 | Entry of appearance for Erin M. Sommers as of counsel for Appellee Biogen MA Inc.. Service: 04/22/2020 by email. [689277] [20-1673] [Erin Sommers] [Entered: 04/22/2020 04:22 PM] (1) |
| Apr 22, 2020 | 3 | Entry of appearance for Mark J. Feldstein as of counsel for Appellee Biogen MA Inc.. Service: 04/22/2020 by email. [689275] [20-1673] [Mark Feldstein] [Entered: 04/22/2020 04:18 PM] (1) |
| Apr 22, 2020 | 2 | Entry of appearance for Barbara C. McCurdy as principal counsel for Appellee Biogen MA Inc.. Service: 04/22/2020 by email. [689270] [20-1673] [Barbara McCurdy] [Entered: 04/22/2020 04:11 PM] (1) |
| Apr 9, 2020 | 1 | Appeal docketed. Received: 04/03/2020. [685575] Entry of Appearance is due 04/23/2020. Certificate of Interest is due on 04/23/2020. Docketing Statement is due 04/23/2020. Certified List is due on 05/19/2020. [LMN] [Entered: 04/09/2020 11:52 AM] (64) |
